Health

A common painkiller may be quietly changing cancer risk

January 20, 2026

Science News from research organizations A common painkiller may be quietly changing cancer risk Date: January 20, 2026 Source: The Conversation Summary: Ibuprofen may be doing more than easing aches and pains—it could also help reduce the risk of some cancers. Studies have linked regular use to lower rates of endometrial and bowel cancer, likely because the drug dampens inflammation that fuels tumor growth. Researchers have even found it can interfere with genes cancer cells rely on to survive.

That everyday ibuprofen in your cabinet might be doing more than fighting pain—it could be quietly fighting cancer too

Credit: Shutterstock

Key Highlights

Still, experts warn that long-term use carries risks and shouldn’t replace proven prevention strategies.
Share: Facebook Pinterest LinkedIN Email FULL STORY That everyday ibuprofen in your cabinet might be doing more than fighting pain—it could be quietly fighting cancer too.
Credit: Shutterstock Ibuprofen is one of the most widely used pain relievers in the United States, commonly taken for headaches, muscle aches, and menstrual pain.
New research suggests this familiar medication may have effects that go beyond pain relief.
Scientists are now examining whether it could also play a role in lowering the risk of certain cancers.

Sources

A common painkiller may be quietly changing cancer risk

This quick summary is automatically generated using AI based on reports from multiple news sources. The content has not been reviewed or verified by humans. For complete details, accuracy, and context, please refer to the original published articles.

A common painkiller may be quietly changing cancer risk

Key Highlights

Sources

Related Stories

Scientists solve a major roadblock holding back cancer cell therapy

Global midwife shortage raises rates of maternity intervention, report warns

Why Do I Always Fall Sick?